According to the literature, MALAT1 is strongly overexpressed in a variety of tumor types, including hepatoblastomas [69], hepatocellular carcinomas [53], [70], breast cancer [71], and endometrial stromal sarcomas [72]. Here, MALAT1 is linked to breast cancer.